{"transactions":[{"id":912667,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-10T16:15:09.000Z","date":"2026-02-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":28500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") by and among the Issuer, SANOFI, a French societe anonyme (\"Parent\"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned\nsubsidiary of Parent (\"Purchaser\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the \"Common Stock\"), for $15.50 per share (the \"Offer Price\"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the \"Effective Time\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time held by the Reporting Person became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time held by the Reporting Person became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time held by the Reporting Person became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option."}],"balance_after":0,"derivative":{"exercise_price":10.18,"underlying":"Common Stock","underlying_shares":28500},"source":{"system":"sec-edgar","filing":"0001286710-26-000002","document":"form4-02102026_040203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000128671026000002/form4-02102026_040203.xml","form_type":"4"}},{"id":912666,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-10T16:15:09.000Z","date":"2026-02-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":22500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") by and among the Issuer, SANOFI, a French societe anonyme (\"Parent\"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned\nsubsidiary of Parent (\"Purchaser\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the \"Common Stock\"), for $15.50 per share (the \"Offer Price\"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the \"Effective Time\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time held by the Reporting Person became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time held by the Reporting Person became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time held by the Reporting Person became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option."}],"balance_after":0,"derivative":{"exercise_price":11.85,"underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001286710-26-000002","document":"form4-02102026_040203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000128671026000002/form4-02102026_040203.xml","form_type":"4"}},{"id":912665,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-10T16:15:09.000Z","date":"2026-02-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":22500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") by and among the Issuer, SANOFI, a French societe anonyme (\"Parent\"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned\nsubsidiary of Parent (\"Purchaser\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the \"Common Stock\"), for $15.50 per share (the \"Offer Price\"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the \"Effective Time\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time held by the Reporting Person became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time held by the Reporting Person became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time held by the Reporting Person became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option."}],"balance_after":0,"derivative":{"exercise_price":11.2,"underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001286710-26-000002","document":"form4-02102026_040203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000128671026000002/form4-02102026_040203.xml","form_type":"4"}},{"id":912664,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-10T16:15:09.000Z","date":"2026-02-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":22500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") by and among the Issuer, SANOFI, a French societe anonyme (\"Parent\"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned\nsubsidiary of Parent (\"Purchaser\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the \"Common Stock\"), for $15.50 per share (the \"Offer Price\"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the \"Effective Time\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time held by the Reporting Person became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time held by the Reporting Person became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time held by the Reporting Person became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option."}],"balance_after":0,"derivative":{"exercise_price":11.68,"underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001286710-26-000002","document":"form4-02102026_040203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000128671026000002/form4-02102026_040203.xml","form_type":"4"}},{"id":912663,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-10T16:15:09.000Z","date":"2026-02-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") by and among the Issuer, SANOFI, a French societe anonyme (\"Parent\"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned\nsubsidiary of Parent (\"Purchaser\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the \"Common Stock\"), for $15.50 per share (the \"Offer Price\"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the \"Effective Time\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time held by the Reporting Person became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time held by the Reporting Person became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time held by the Reporting Person became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option."}],"balance_after":0,"derivative":{"exercise_price":8.2,"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001286710-26-000002","document":"form4-02102026_040203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000128671026000002/form4-02102026_040203.xml","form_type":"4"}},{"id":912662,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-10T16:15:09.000Z","date":"2026-02-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") by and among the Issuer, SANOFI, a French societe anonyme (\"Parent\"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned\nsubsidiary of Parent (\"Purchaser\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the \"Common Stock\"), for $15.50 per share (the \"Offer Price\"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the \"Effective Time\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time held by the Reporting Person became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time held by the Reporting Person became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the terms of the Merger Agreement, (i) each stock option that was outstanding as of immediately prior to the Effective Time held by the Reporting Person became fully vested immediately prior to the Effective Time, and (ii) at the Effective Time, each stock option that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares subject to such stock option immediately prior to the Effective Time, without regard to vesting, multiplied by (ii) the excess of the Offer Price over the exercise price per share of such stock option."}],"balance_after":0,"derivative":{"exercise_price":4.84,"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001286710-26-000002","document":"form4-02102026_040203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000128671026000002/form4-02102026_040203.xml","form_type":"4"}},{"id":912661,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock - Restricted Stock Units","published_at":"2026-02-10T16:15:09.000Z","date":"2026-02-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":42663,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities transacted pursuant to the Agreement and Plan of Merger (the \"Merger Agreement\") by and among the Issuer, SANOFI, a French societe anonyme (\"Parent\"), and Samba Merger Sub, Inc., a Delaware corporation and wholly owned\nsubsidiary of Parent (\"Purchaser\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, Purchaser completed a tender offer to acquire all of the issued and outstanding shares of common stock of the Issuer, par value $0.001 per share (the \"Common Stock\"), for $15.50 per share (the \"Offer Price\"), in cash, without interest and subject to any applicable withholding of taxes. On February 10, 2026, Purchaser merged with and into the Issuer, with the Issuer surviving as an indirect wholly owned subsidiary of Parent (the effective time of such merger, the \"Effective Time\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, at the Effective Time, each restricted stock unit (\"RSU\") award that was outstanding as of immediately prior to the Effective Time held by the Reporting Person, whether vested or unvested, was cancelled and converted into the right to receive cash in an amount equal to (i) the number of shares issuable in settlement of such RSU award immediately prior to the Effective Time without regard to vesting, multiplied by (ii) the Offer Price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001286710-26-000002","document":"form4-02102026_040203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000128671026000002/form4-02102026_040203.xml","form_type":"4"}},{"id":1112255,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T17:39:49.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":28500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option grant fully vests and becomes exercisable one year from date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date."}],"balance_after":28500,"derivative":{"exercise_price":10.18,"expiration_date":"2032-06-10","underlying":"Commont Stock","underlying_shares":28500},"source":{"system":"sec-edgar","filing":"0001029142-25-000091","document":"wk-form4_1749850783.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000102914225000091/wk-form4_1749850783.xml","form_type":"4"}},{"id":1112254,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-13T17:39:49.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":5758,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of DVAX Common Stock. The RSU will fully vest one year from the date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date. The release of RSU shares shall be mandatorily deferred six months and one day after the Reporting Person no longer provides services to the Company."}],"balance_after":42663,"source":{"system":"sec-edgar","filing":"0001029142-25-000091","document":"wk-form4_1749850783.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000102914225000091/wk-form4_1749850783.xml","form_type":"4"}},{"id":1495598,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-03T17:37:54.000Z","date":"2024-05-31","kind":"sale","planned":false,"acquired":false,"shares":3615,"price":11.93,"value":43126.95,"ownership":{"direct":true},"balance_after":36905,"source":{"system":"sec-edgar","filing":"0000950170-24-068141","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000095017024068141/ownership.xml","form_type":"4"}},{"id":1500879,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-28T20:18:05.000Z","date":"2024-05-24","kind":"exercise","planned":false,"acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option grant fully vests and becomes exercisable one year from date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date."}],"balance_after":0,"derivative":{"exercise_price":5.9,"expiration_date":"2024-06-01","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0000950170-24-065571","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000095017024065571/ownership.xml","form_type":"4"}},{"id":1500878,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-28T20:18:05.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option grant fully vests and becomes exercisable one year from date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date."}],"balance_after":22500,"derivative":{"exercise_price":11.79,"expiration_date":"2031-05-22","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0000950170-24-065571","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000095017024065571/ownership.xml","form_type":"4"}},{"id":1500877,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-28T20:18:05.000Z","date":"2024-05-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":3885,"price":11.39,"value":44250.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld to cover option exercise cost."}],"balance_after":40520,"source":{"system":"sec-edgar","filing":"0000950170-24-065571","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000095017024065571/ownership.xml","form_type":"4"}},{"id":1500876,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-28T20:18:05.000Z","date":"2024-05-24","kind":"exercise","planned":false,"acquired":true,"shares":7500,"price":5.9,"value":44250.0,"ownership":{"direct":true},"balance_after":44405,"source":{"system":"sec-edgar","filing":"0000950170-24-065571","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000095017024065571/ownership.xml","form_type":"4"}},{"id":1500875,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-28T20:18:05.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":5357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of DVAX Common Stock. The RSU will fully vest one year from the date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date. The release of RSU shares shall be mandatorily deferred six months and one day after the Reporting Person no longer provides services to the Company."}],"balance_after":36905,"source":{"system":"sec-edgar","filing":"0000950170-24-065571","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000095017024065571/ownership.xml","form_type":"4"}},{"id":1873670,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-05-31T17:20:32.000Z","date":"2023-05-26","kind":"grant","planned":false,"acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option grant fully vests and becomes exercisable one year from date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date."}],"balance_after":22500,"derivative":{"exercise_price":11.2,"expiration_date":"2030-05-25","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001209191-23-033154","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000120919123033154/doc4.xml","form_type":"4"}},{"id":1873669,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-31T17:20:32.000Z","date":"2023-05-26","kind":"grant","planned":false,"acquired":true,"shares":5357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of DVAX Common Stock. The RSU will fully vest one year from the date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date. The release of RSU shares shall be mandatorily deferred six months and one day after the Reporting Person no longer provides services to the Company. The reporting person has reported prior awards of restricted stock units in Table II on Form 4. The total reported in Column 5 includes 5,357 newly awarded restricted stock units, 5,357 restricted stock units previously reported in Table II, and 20,834 shares of common stock."}],"balance_after":31548,"source":{"system":"sec-edgar","filing":"0001209191-23-033154","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000120919123033154/doc4.xml","form_type":"4"}},{"id":2189892,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-10T20:21:15.000Z","date":"2022-08-08","kind":"exercise","acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options fully-vested on May 30, 2020, upon the one-year anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":4.97,"expiration_date":"2026-05-29","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-22-045321","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000120919122045321/doc4.xml","form_type":"4"}},{"id":2189891,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-10T20:21:15.000Z","date":"2022-08-08","kind":"sale","acquired":false,"shares":15000,"price":17.17,"value":257550.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $17.16 to $17.20; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Dynavax, or a security holder of Dynavax."}],"balance_after":20834,"source":{"system":"sec-edgar","filing":"0001209191-22-045321","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000120919122045321/doc4.xml","form_type":"4"}},{"id":2189890,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-10T20:21:15.000Z","date":"2022-08-08","kind":"exercise","acquired":true,"shares":15000,"price":4.97,"value":74550.0,"ownership":{"direct":true},"balance_after":35834,"source":{"system":"sec-edgar","filing":"0001209191-22-045321","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000120919122045321/doc4.xml","form_type":"4"}},{"id":2254035,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2022-05-27T17:01:06.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":22500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option grant fully vests and becomes exercisable one year from date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date."}],"balance_after":22500,"derivative":{"exercise_price":11.68,"expiration_date":"2029-05-25","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001209191-22-032611","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000120919122032611/doc4.xml","form_type":"4"}},{"id":2254034,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-05-27T17:01:06.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":5357,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of common stock.  The RSU will fully vest one year from the date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date. The release of RSU shares shall be mandatorily deferred until the Reporting Person no longer provides services to the Company."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of common stock.  The RSU will fully vest one year from the date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date. The release of RSU shares shall be mandatorily deferred until the Reporting Person no longer provides services to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of common stock.  The RSU will fully vest one year from the date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date. The release of RSU shares shall be mandatorily deferred until the Reporting Person no longer provides services to the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of common stock.  The RSU will fully vest one year from the date of grant, provided that Reporting Person continues to provide services to the Company through such vesting date. The release of RSU shares shall be mandatorily deferred until the Reporting Person no longer provides services to the Company."}],"balance_after":5357,"derivative":{"underlying":"Common Stock","underlying_shares":5357},"source":{"system":"sec-edgar","filing":"0001209191-22-032611","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000120919122032611/doc4.xml","form_type":"4"}},{"id":2591288,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2021-08-25T19:32:24.000Z","date":"2021-08-24","kind":"exercise","acquired":false,"shares":4167,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Warrants were issued in connection with a financing transaction dated August 12, 2019 and were immediately exercisable upon issuance and\nhave an expiration date of February 12, 2022."}],"balance_after":0,"derivative":{"exercise_price":4.5,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":4167},"source":{"system":"sec-edgar","filing":"0001209191-21-053376","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000120919121053376/doc4.xml","form_type":"4"}},{"id":2591287,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-25T19:32:24.000Z","date":"2021-08-24","kind":"exercise","acquired":true,"shares":4167,"price":4.5,"value":18751.5,"ownership":{"direct":true},"balance_after":20834,"source":{"system":"sec-edgar","filing":"0001209191-21-053376","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000120919121053376/doc4.xml","form_type":"4"}},{"id":2687290,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2021-06-02T19:03:12.000Z","date":"2021-05-28","kind":"grant","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests fully on May 28, 2022, on the one year anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":8.2,"expiration_date":"2028-05-27","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-21-037418","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000120919121037418/doc4.xml","form_type":"4"}},{"id":2949527,"issuer":{"id":8171,"kind":"organization","name":"BIOMERICA INC","symbol":"BMRA"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option","published_at":"2020-12-12T01:26:16.000Z","date":"2020-12-10","kind":"grant","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable"}],"balance_after":175000,"derivative":{"exercise_price":6.36,"exercise_date":"2021-12-10","expiration_date":"2030-12-10","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001513162-20-000240","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/73290/000151316220000240/primary_doc.xml","form_type":"4"}},{"id":2949526,"issuer":{"id":8171,"kind":"organization","name":"BIOMERICA INC","symbol":"BMRA"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-12T01:26:16.000Z","date":"2020-10-05","kind":"gift","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Transaction was a gift, no monetary price assigned"}],"balance_after":146736,"source":{"system":"sec-edgar","filing":"0001513162-20-000240","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/73290/000151316220000240/primary_doc.xml","form_type":"4"}},{"id":3131049,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2020-05-29T16:32:24.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests fully on May 28, 2021, on the one year anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":4.84,"expiration_date":"2027-05-27","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-20-032949","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000120919120032949/doc4.xml","form_type":"4"}},{"id":3333319,"issuer":{"id":8171,"kind":"organization","name":"BIOMERICA INC","symbol":"BMRA"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualified Stock Option","published_at":"2019-12-23T21:29:34.000Z","date":"2019-12-19","kind":"grant","acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable."}],"balance_after":155000,"derivative":{"exercise_price":2.81,"exercise_date":"2020-12-20","expiration_date":"2029-12-20","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001513162-19-000258","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/73290/000151316219000258/primary_doc.xml","form_type":"4"}},{"id":3441424,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (Right to Buy)","published_at":"2019-08-12T19:24:43.000Z","date":"2019-08-12","kind":"purchase","acquired":true,"shares":4167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediate"}],"balance_after":4167,"derivative":{"exercise_price":4.5,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":4167},"source":{"system":"sec-edgar","filing":"0001209191-19-045638","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000120919119045638/doc4.xml","form_type":"4"}},{"id":3441423,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-12T19:24:43.000Z","date":"2019-08-12","kind":"purchase","acquired":true,"shares":16667,"price":3,"value":50001.0,"ownership":{"direct":true},"balance_after":16667,"source":{"system":"sec-edgar","filing":"0001209191-19-045638","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000120919119045638/doc4.xml","form_type":"4"}},{"id":3506615,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2019-05-31T18:27:20.000Z","date":"2019-05-30","kind":"grant","acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests fully on May 30, 2020, on the one year anniversary of the grant date."}],"balance_after":15000,"derivative":{"exercise_price":4.97,"expiration_date":"2026-05-29","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-19-033720","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000120919119033720/doc4.xml","form_type":"4"}},{"id":3722994,"issuer":{"id":8171,"kind":"organization","name":"BIOMERICA INC","symbol":"BMRA"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualified Stock Option","published_at":"2018-12-21T23:01:14.000Z","date":"2018-12-20","kind":"grant","acquired":true,"shares":35000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Not applicable"}],"balance_after":125000,"derivative":{"exercise_price":2.25,"exercise_date":"2019-12-20","expiration_date":"2028-12-20","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001513162-18-000322","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/73290/000151316218000322/primary_doc.xml","form_type":"4"}},{"id":3740064,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-07T19:23:56.000Z","date":"2018-12-06","kind":"sale","acquired":false,"shares":2000,"price":10.471,"value":20942.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold at prices ranging from $10.47 to $10.48. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-061656","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000120919118061656/doc4.xml","form_type":"4"}},{"id":3782708,"issuer":{"id":8171,"kind":"organization","name":"BIOMERICA INC","symbol":"BMRA"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualified Stock Option","published_at":"2018-10-26T18:25:43.000Z","date":"2018-10-26","kind":"other","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"To report exercise of stock option."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Consists of various options reported previously with varying dates and prices both expiring and excercisable."}],"balance_after":90000,"derivative":{"exercise_price":0.75,"exercise_date":"2012-10-30","expiration_date":"2018-10-30","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001513162-18-000271","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/73290/000151316218000271/primary_doc.xml","form_type":"4"}},{"id":3782707,"issuer":{"id":8171,"kind":"organization","name":"BIOMERICA INC","symbol":"BMRA"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-26T18:25:43.000Z","date":"2018-10-26","kind":"exercise","acquired":true,"shares":25000,"price":0.75,"value":18750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"To report exercise of stock option."}],"balance_after":166736,"source":{"system":"sec-edgar","filing":"0001513162-18-000271","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/73290/000151316218000271/primary_doc.xml","form_type":"4"}},{"id":3911220,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2018-06-01T17:02:22.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests fully on May 31, 2019, on the one year anniversary of the grant date."}],"balance_after":15000,"derivative":{"exercise_price":15.8,"expiration_date":"2025-05-30","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-18-034758","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000120919118034758/doc4.xml","form_type":"4"}},{"id":3918114,"issuer":{"id":8171,"kind":"organization","name":"BIOMERICA INC","symbol":"BMRA"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-25T17:45:33.000Z","date":"2018-05-23","kind":"other","acquired":true,"shares":8000,"price":3.73,"value":29840.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Purchased through an S-3 registration statement filed 06/30/2017, file #333-219130. (Prospectus filed 12/04/2017)"}],"balance_after":141736,"source":{"system":"sec-edgar","filing":"0001513162-18-000140","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/73290/000151316218000140/primary_doc.xml","form_type":"4"}},{"id":4090596,"issuer":{"id":8171,"kind":"organization","name":"BIOMERICA INC","symbol":"BMRA"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-25T22:05:58.000Z","date":"2018-01-25","kind":"purchase","acquired":true,"shares":2500,"price":4.18,"value":10450.0,"ownership":{"direct":false,"nature":"Spouse"},"balance_after":5900,"source":{"system":"sec-edgar","filing":"0001513162-18-000033","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/73290/000151316218000033/primary_doc.xml","form_type":"4"}},{"id":4090595,"issuer":{"id":8171,"kind":"organization","name":"BIOMERICA INC","symbol":"BMRA"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-25T22:05:58.000Z","date":"2018-01-24","kind":"purchase","acquired":true,"shares":3400,"price":4.18,"value":14212.0,"ownership":{"direct":false,"nature":"Spouse"},"balance_after":3400,"source":{"system":"sec-edgar","filing":"0001513162-18-000033","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/73290/000151316218000033/primary_doc.xml","form_type":"4"}},{"id":4090594,"issuer":{"id":8171,"kind":"organization","name":"BIOMERICA INC","symbol":"BMRA"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-25T22:05:58.000Z","date":"2018-01-25","kind":"purchase","acquired":true,"shares":5700,"price":4.18,"value":23826.0,"ownership":{"direct":true},"balance_after":133736,"source":{"system":"sec-edgar","filing":"0001513162-18-000033","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/73290/000151316218000033/primary_doc.xml","form_type":"4"}},{"id":4090593,"issuer":{"id":8171,"kind":"organization","name":"BIOMERICA INC","symbol":"BMRA"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-25T22:05:58.000Z","date":"2018-01-24","kind":"purchase","acquired":true,"shares":200,"price":4.18,"value":836.0,"ownership":{"direct":true},"balance_after":128036,"source":{"system":"sec-edgar","filing":"0001513162-18-000033","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/73290/000151316218000033/primary_doc.xml","form_type":"4"}},{"id":4091895,"issuer":{"id":8171,"kind":"organization","name":"BIOMERICA INC","symbol":"BMRA"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non qualified stock option","published_at":"2018-01-24T23:48:49.000Z","date":"2018-01-22","kind":"grant","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable 01/22/2019."}],"balance_after":115000,"derivative":{"exercise_price":3.9,"expiration_date":"2028-01-22","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001513162-18-000028","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/73290/000151316218000028/primary_doc.xml","form_type":"4"}},{"id":4296359,"issuer":{"id":66930,"kind":"organization","name":"DYNAVAX TECHNOLOGIES CORP","symbol":"DVAX"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2017-06-02T18:05:46.000Z","date":"2017-06-02","kind":"grant","acquired":true,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests fully on June 2, 2018, on the one year anniversary of the grant date."}],"balance_after":7500,"derivative":{"exercise_price":5.9,"expiration_date":"2024-06-01","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-17-037412","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029142/000120919117037412/doc4.xml","form_type":"4"}},{"id":4549765,"issuer":{"id":8171,"kind":"organization","name":"BIOMERICA INC","symbol":"BMRA"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-qualified stock option","published_at":"2016-11-18T18:02:09.000Z","date":"2016-11-17","kind":"other","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Consists of various options previously reported with varying dates expiring and prices exercisable"}],"balance_after":90000,"derivative":{"exercise_price":0.43,"exercise_date":"2015-01-05","expiration_date":"2017-01-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001513162-16-001083","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/73290/000151316216001083/primary_doc.xml","form_type":"4"}},{"id":4549764,"issuer":{"id":8171,"kind":"organization","name":"BIOMERICA INC","symbol":"BMRA"},"owners":[{"id":67087,"kind":"person","name":"CANO FRANCIS","position":1,"cik":"0001286710","reported_name":"CANO FRANCIS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-18T18:02:09.000Z","date":"2016-11-17","kind":"exercise","acquired":true,"shares":25000,"price":0.43,"value":10750.0,"ownership":{"direct":true},"balance_after":127836,"source":{"system":"sec-edgar","filing":"0001513162-16-001083","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/73290/000151316216001083/primary_doc.xml","form_type":"4"}}]}